Idarucizumab, a Specific Dabigatran Reversal Agent, Reduces Blood Loss in a Porcine Model of Trauma With Dabigatran Anticoagulation

Oliver Grottke*, Markus Honickel, Joanne van Ryn, Hugo ten Cate, Rolf Rossaint, Henri M. Spronk

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1518-1519
JournalJournal of the American College of Cardiology
Issue number13
Publication statusPublished - 29 Sept 2015

Cite this